Bexarotene
Brand name: Bexarotene
Rank #490 of 500 drugs by total cost
$14.2M
Total Cost
1,613
Total Claims
$14.2M
Total Cost
66
Prescribers
$8,832
Cost per Claim
75
Beneficiaries
1,686
30-Day Fills
$216K
Avg Cost/Provider
24
Avg Claims/Provider
About Bexarotene
Bexarotene (sold as Bexarotene) was prescribed 1,613 times by 66 Medicare Part D providers in 2023, costing the program $14.2M. At $8,832 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
| 490 | Bexarotene (Bexarotene) | $14.2M | 1,613 |
| 491 | Ozanimod Hydrochloride (Zeposia) | $14.2M | 1,535 |
| 492 | Enoxaparin Sodium (Enoxaparin Sodium) | $14.2M | 93,202 |
| 493 | Omadacycline Tosylate (Nuzyra) | $14.1M | 1,395 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology